These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7742157)

  • 1. Methylprednisolone-hemisuccinate and its metabolites in serum, urine and bile from two patients with acute graft rejection.
    Lawson GJ; Chakraborty J; Tredger JM; Baylis EM
    Br J Clin Pharmacol; 1995 Feb; 39(2):176-8. PubMed ID: 7742157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylprednisolone hemisuccinate and metabolites in urine from patients receiving high-dose corticosteroid therapy.
    Lawson GJ; Chakraborty J; Dumasia MC; Baylis EM
    Ther Drug Monit; 1992 Feb; 14(1):20-6. PubMed ID: 1546386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease.
    Ludwig EA; Kong AN; Camara DS; Jusko WJ
    J Clin Pharmacol; 1993 Sep; 33(9):805-10. PubMed ID: 8227476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass.
    Kong AN; Jungbluth GL; Pasko MT; Beam TR; Jusko WJ
    Pharmacotherapy; 1990; 10(1):29-34. PubMed ID: 2179900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of methylprednisolone in accident victims with spinal cord injury.
    Barth J; Winkler J; Schumann R; Nagaraja NV; Madabushi R; Balbach S; Derendorf H; Möllmann H; Möllenhoff G
    Int J Clin Pharmacol Ther; 2004 Sep; 42(9):504-11. PubMed ID: 15487809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and patterns of rejection using different induction therapies in liver transplant recipients.
    Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G
    Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics of methylprednisolone and its hemisuccinate ester.
    Derendorf H; Möllmann H; Rohdewald P; Rehder J; Schmidt EW
    Clin Pharmacol Ther; 1985 May; 37(5):502-7. PubMed ID: 3886255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high doses.
    Möllmann H; Rohdewald P; Barth J; Möllmann C; Verho M; Derendorf H
    Pharm Res; 1988 Aug; 5(8):509-13. PubMed ID: 3072558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid method for the measurement of methylprednisolone and its hemisuccinate in plasma and urine following "pulse therapy" by high-performance liquid chromatography.
    Lawson GJ
    J Chromatogr; 1985 Aug; 342(2):251-60. PubMed ID: 3902861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: a controlled clinical trial.
    Volpin R; Angeli P; Galioto A; Fasolato S; Neri D; Barbazza F; Merenda R; Del Piccolo F; Strazzabosco M; Casagrande F; Feltracco P; Sticca A; Merkel C; Gerunda G; Gatta A
    Liver Transpl; 2002 Jun; 8(6):527-34. PubMed ID: 12037783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fate of soluble steroids within breast prostheses in humans.
    Morykwas MJ; Argenta LC; Oneal RM; Kaiser DG
    Ann Plast Surg; 1990 May; 24(5):427-30. PubMed ID: 2190525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
    Levy GA
    Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolated acute cellular rejection of the liver after simultaneous liver and kidney transplantation: a case report.
    Nah YW; Nam CW; Suh JH; Cha HJ; Kim GY; Park SJ; Oh Y; Cho HR
    Transplant Proc; 2008 Oct; 40(8):2832-4. PubMed ID: 18929875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of methylprednisolone during acute renal allograft rejection.
    Tornatore KM; Walshe JJ; Reed K; Venuto RC
    Clin Transplant; 1995 Apr; 9(2):74-8. PubMed ID: 7599405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diphenylhydantoin, phenobarbital, and diazepam on the metabolism of methylprednisolone and its sodium succinate.
    Stjernholm MR; Katz FH
    J Clin Endocrinol Metab; 1975 Nov; 41(5):887-93. PubMed ID: 1184723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic determination of hydrocortisone and methylprednisolone and their hemisuccinate esters in human serum.
    Smith MD
    J Chromatogr; 1979 Oct; 164(2):129-37. PubMed ID: 541404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of interleukin-6, tumor necrosis factor-alpha, and interleukin-2 in rejecting human small bowel allografts.
    Noguchi K; Yoshida Y; Yagihashi A; Kita Y; Takenaka T; Terasawa K; Hayashi S; Konno A; Kobayashi M; Nakamura K
    Transplant Proc; 1992 Jun; 24(3):1152. PubMed ID: 1604565
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose methylprednisolone sodium succinate (pulse therapy) in the treatment of renal disease: plasma and urine concentrations.
    Searle M; Lawson G; Chakraborty J; Baylis EM; Lee HA; Marks V
    Eur J Clin Pharmacol; 1985; 28(3):245-8. PubMed ID: 3891379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.